Malaria D008288

Diseases [C] » Infections [C01] » Parasitic Diseases » Protozoan Infections » Malaria

Diseases [C] » Infections [C01] » Vector Borne Diseases » Malaria

Description

A protozoan disease caused in humans by four species of the PLASMODIUM genus: PLASMODIUM FALCIPARUM; PLASMODIUM VIVAX; PLASMODIUM OVALE; and PLASMODIUM MALARIAE; and transmitted by the bite of an infected female mosquito of the genus ANOPHELES. Malaria is endemic in parts of Asia, Africa, Central and South America, Oceania, and certain Caribbean islands. It is characterized by extreme exhaustion associated with paroxysms of high FEVER; SWEATING; shaking CHILLS; and ANEMIA. Malaria in ANIMALS is caused by other species of plasmodia.   MeSH

Subtype Terms (4)

Malaria, Avian
 

Malaria, Cerebral
7 approved drugs

Malaria, Falciparum
123 drugs (35 approved, 88 experimental)

Malaria, Vivax
38 drugs (16 approved, 22 experimental)



Organization Involved with Phase 4 Indications (166)

Medecins Sans Frontieres

Medical Research and Training Centre, Mali

Medical Research Council

Medical Research Council, The Gambia

Medical Research Unit, Lambarene

Medicines for Malaria Venture

Menzies School of Health Research

Mepha Ltd.

Muhimbili University

Nangarhar University

National Center for Parasitology, Entomology and Malaria Control

National Centre for Parasitology, Entomology and Malaria Control, Cambodia

National Heart, Lung, and Blood Institute (NHLBI)

National Institute for Medical Research, Tanzania

National Institute of Allergy and Infectious Diseases (NIAID)

National Institute of Child Health and Human Development (NICHD)

National Institute of Malariology, Parasitology and Entomology, Vietnam

National Institutes of Health (NIH)

National Malaria and Leishmaniasis Control Program, Afghanistan

Navrongo Health Research Centre, Ghana

Oromia Regional Health Bureau, Ethiopia

Pan American Health Organization

Papua New Guinea Institute of Medical Research

Partnership for Child Development

PATH

PNG Institute of Medical Research

Radboud University

Sanofi

School of Medical Sciences Kumasi

Senegal: Ministere de la Sante

Shin Poong Pharmaceuticals

Southeast University

The University of Texas, Dallas

The Volkswagen Foundation

Thrasher Research Fund

Timika Research Facility, Indonesia

Tribhuvan University

Tropical Diseases Hospital, Ho Chi Minh City

Tropical Pesticides Research Institute, Tanzania

Uganda Malaria Surveillance Project

United Nations

United States Agency for International Development

Organization Involved with Phase 3 Indications (108)

Organization Involved with Phase 2 Indications (65)

Organization Involved with Phase 1 Indications (65)

Organization Involved with Other Experimental Indications (44)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.